{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:58:28Z","timestamp":1790423908074,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00198-019-05033-3","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T07:02:42Z","timestamp":1560322962000},"page":"2019-2025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease"],"prefix":"10.1007","volume":"30","author":[{"given":"S.","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"Peissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maursetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-6073","authenticated-orcid":false,"given":"K.E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"5033_CR1","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. Jama 298:2038\u20132047","journal-title":"Jama"},{"key":"5033_CR2","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (2016) kidney disease statistics for the United States. Accessed November 27, 2018"},{"key":"5033_CR3","doi-asserted-by":"crossref","unstructured":"Saran R, Li Y, Robinson B et al (2015) US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 66(Svii):S1\u2013S305","DOI":"10.1053\/j.ajkd.2015.05.001"},{"key":"5033_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338","journal-title":"Kidney Int"},{"key":"5033_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-1797.2007.00860.x","volume":"13","author":"A Stavroulopoulos","year":"2008","unstructured":"Stavroulopoulos A, Porter CJ, Roe SD, Hosking DJ, Cassidy MJ (2008) Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology (Carlton) 13:63\u201367","journal-title":"Nephrology (Carlton)"},{"key":"5033_CR6","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1038\/ki.2008.543","volume":"74","author":"AM Ramos","year":"2008","unstructured":"Ramos AM, Albalate M, Vazquez S, Caramelo C, Egido J, Ortiz A (2008) Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients. Kidney Int Suppl 74:S88\u2013S93","journal-title":"Kidney Int Suppl"},{"key":"5033_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2009.188","volume":"76","author":"Kai-Uwe Eckardt","year":"2009","unstructured":"(2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD). Kidney Int Suppl (113):S1\u2013130 https:\/\/doi.org\/10.1038\/ki.2009.188","journal-title":"Kidney International"},{"key":"5033_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/8756-3282(92)90201-7","volume":"13","author":"ML Bianchi","year":"1992","unstructured":"Bianchi ML, Colantonio G, Montesano A, Trevisan C, Ortolani S, Rossi R, Buccianti G (1992) Bone mass status in different degrees of chronic renal failure. Bone 13:225\u2013228","journal-title":"Bone"},{"key":"5033_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084\u20131093","journal-title":"Kidney Int"},{"key":"5033_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00198-004-1655-9","volume":"16","author":"T Tsuchida","year":"2005","unstructured":"Tsuchida T, Ishimura E, Miki T, Matsumoto N, Naka H, Jono S, Inaba M, Nishizawa Y (2005) The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure. Osteoporos Int 16:172\u2013179","journal-title":"Osteoporos Int"},{"key":"5033_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000188515","volume":"69","author":"J Przedlacki","year":"1995","unstructured":"Przedlacki J, Manelius J, Huttunen K (1995) Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure. Nephron 69:433\u2013437","journal-title":"Nephron"},{"key":"5033_CR12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/ndt\/gfg595","volume":"19","author":"M Rix","year":"2004","unstructured":"Rix M, Eskildsen P, Olgaard K (2004) Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Nephrol Dial Transplant 19:870\u2013876","journal-title":"Nephrol Dial Transplant"},{"key":"5033_CR13","doi-asserted-by":"crossref","unstructured":"(2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1\u2013S201","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"5033_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"KDIGO","year":"2017","unstructured":"KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"5033_CR15","first-page":"21","volume":"51","author":"P Gao","year":"2005","unstructured":"Gao P, D'Amour P (2005) Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation. Clin Lab 51:21\u201329","journal-title":"Clin Lab"},{"key":"5033_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5414\/CNP72005","volume":"72","author":"J Herberth","year":"2009","unstructured":"Herberth J, Monier-Faugere MC, Mawad HW, Branscum AJ, Herberth Z, Wang G, Cantor T, Malluche HH (2009) The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients. Clin Nephrol 72:5\u201314","journal-title":"Clin Nephrol"},{"key":"5033_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jdiacomp.2014.10.003","volume":"29","author":"EM Magnan","year":"2015","unstructured":"Magnan EM, Palta M, Johnson HM, Bartels CM, Schumacher JR, Smith MA (2015) The impact of a patient's concordant and discordant chronic conditions on diabetes care quality measures. J Diabetes Complicat 29:288\u2013294","journal-title":"J Diabetes Complicat"},{"key":"5033_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/jch.12596","volume":"17","author":"HM Johnson","year":"2015","unstructured":"Johnson HM, Bartels CM, Thorpe CT, Schumacher JR, Pandhi N, Smith MA (2015) Differential diagnosis and treatment rates between systolic and diastolic hypertension in young adults: a multidisciplinary observational study. J Clin Hypertens (Greenwich) 17:885\u2013894","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"5033_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM (2000) Modeling survival data: extending the cox model. Springer-Verlag, New York"},{"key":"5033_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning : data mining, inference, and prediction","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman JH (2009) The elements of statistical learning : data mining, inference, and prediction. Springer, New York, NY"},{"key":"5033_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00198-016-3797-y","volume":"28","author":"M Iki","year":"2017","unstructured":"Iki M, Fujita Y, Tamaki J, Kouda K, Yura A, Sato Y, Moon JS, Harano A, Hazaki K, Kajita E, Hamada M, Arai K, Tomioka K, Okamoto N, Kurumatani N (2017) Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo osteoporosis risk in men (FORMEN) cohort study. Osteoporos Int 28:871\u2013880","journal-title":"Osteoporos Int"},{"key":"5033_CR22","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1001\/jama.293.17.2102","volume":"293","author":"JA Cauley","year":"2005","unstructured":"Cauley JA, Lui LY, Ensrud KE, Zmuda JM, Stone KL, Hochberg MC, Cummings SR (2005) Bone mineral density and the risk of incident nonspinal fractures in black and white women. Jama 293:2102\u20132108","journal-title":"Jama"},{"key":"5033_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.semnephrol.2003.08.013","volume":"24","author":"C Stehman-Breen","year":"2004","unstructured":"Stehman-Breen C (2004) Osteoporosis and chronic kidney disease. Semin Nephrol 24:78\u201381","journal-title":"Semin Nephrol"},{"key":"5033_CR24","unstructured":"(July 2016) QickFacts; Marshfield, Wisconsin. United States Census Bureau,"},{"key":"5033_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/ki.2015.72","volume":"88","author":"H Komaba","year":"2015","unstructured":"Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350\u2013359","journal-title":"Kidney Int"},{"key":"5033_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10:98\u2013109","journal-title":"Clin J Am Soc Nephrol"},{"key":"5033_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","volume":"44","author":"A Lishmanov","year":"2012","unstructured":"Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A (2012) Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 44:541\u2013547","journal-title":"Int Urol Nephrol"},{"key":"5033_CR28","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Guti\u00e9rrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Group (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. Jama 305:2432\u20132439","journal-title":"Jama"},{"key":"5033_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1681\/ASN.2013050465","volume":"25","author":"JJ Scialla","year":"2014","unstructured":"Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, Kusek JW, Feldman H, Wolf M, the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators (2014) Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 25:349\u2013360","journal-title":"J Am Soc Nephrol"},{"key":"5033_CR30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","volume":"73","author":"N Yu","year":"2010","unstructured":"Yu N, Donnan PT, Flynn RWV, Murphy MJ, Smith D, Rudman A, Leese GP (2010) Increased mortality and morbidity in mild primary hyperparathyroid patients the parathyroid epidemiology and audit research study (PEARS). Clin Endocrinol 73:30\u201334","journal-title":"Clin Endocrinol"},{"key":"5033_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/cen.12206","volume":"79","author":"N Yu","year":"2013","unstructured":"Yu N, Leese GP, Donnan PT (2013) What predicts adverse outcomes in untreated primary hyperparathyroidism? The parathyroid epidemiology and audit research study (PEARS). Clin Endocrinol 79:27\u201334","journal-title":"Clin Endocrinol"},{"key":"5033_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/jch.13064","volume":"19","author":"J Wetzel","year":"2017","unstructured":"Wetzel J, Pilz S, Grubler MR et al (2017) Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: the EPATH trial. J Clin Hypertens (Greenwich) 19:1173\u20131180","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"5033_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MCA.0000000000000089","volume":"25","author":"S Shekarkhar","year":"2014","unstructured":"Shekarkhar S, Foroughi M, Moatamedi M, Gachkar L (2014) The association of serum parathyroid hormone and severity of coronary artery diseases. Coron Artery Dis 25:339\u2013342","journal-title":"Coron Artery Dis"},{"key":"5033_CR34","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1210\/endo.137.8.8754733","volume":"137","author":"S Maeda","year":"1996","unstructured":"Maeda S, Wu S, Juppner H, Green J, Aragay AM, Fagin JA, Clemens TL (1996) Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH\/PTHrP receptors in vascular smooth muscle cells. Endocrinology 137:3154\u20133162","journal-title":"Endocrinology"},{"key":"5033_CR35","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00198-015-3460-z","volume":"27","author":"T Benson","year":"2016","unstructured":"Benson T, Menezes T, Campbell J, Bice A, Hood B, Prisby R (2016) Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries. Osteoporos Int 27:1817\u20131826","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05033-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05033-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05033-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T12:21:11Z","timestamp":1721391671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05033-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["5033"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05033-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"13 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}